** Medical equipment maker TransMedics' TMDX.O shares rise 4.4% to $75 premarket
** Co's Q4 revenue of $121.6 million beats analysts' average expectation of $110.3 million, according to data compiled by LSEG
** TMDX forecasts annual revenue between $530 mln and $552 mln, the midpoint of which is above analysts' average estimate of $539 mln - LSEG
** Up to last close, stock down 18.7% in the last 12 months
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.